1. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression
   Mohammad Salman Akhtar et al, 2023, Oncotarget CrossRef
2. Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation
   Wanxin Yao et al, 2024, Oncology Letters CrossRef
3. Photothermal Therapy via NIR II Light Irradiation Enhances DNA Damage and Endoplasmic Reticulum Stress for Efficient Chemotherapy
   Qingduo Kong et al, 2021, Frontiers in Pharmacology CrossRef
4. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
   Ping Yang et al, 2022, Frontiers in Oncology CrossRef
5. The function of brother of the regulator of imprinted sites in cancer development
   Siqi Zhou et al, 2023, Cancer Gene Therapy CrossRef
6. Key roles of CCCTC-binding factor in cancer evolution and development
   Zishuai Li et al, 2021, Exploration of Medicine CrossRef
7. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer
   Adviti Naik et al, 2024, Molecular Therapy: Oncology CrossRef
8. Boris knockout eliminates AOM/DSS‐induced in situ colorectal cancer by suppressing DNA damage repair and inflammation
   Bo‐Wen Zuo et al, 2023, Cancer Science CrossRef